| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43411-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB600-713-0.25ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86571-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | IC2932V-100UG | |||
| Carrier Free | IC2932U-100UG | |||
| Carrier Free | IC2932T-100UG | |||
| Carrier Free | IC2932S-100UG | |||
| Carrier Free | IC2932R-100UG | |||
| Carrier Free | IC2932N-100UG | |||
| Carrier Free | IC2932G-100UG | |||
![Immunohistochemistry: LYVE-1 Antibody (ALY7) [NBP1-43411] - Immunohistochemistry of cryosections of mouse intestine at 2.5 ug/ml of anti-mouse LYVE-1 antibody followed by Anti-Rat IgG Rhodamine (right). Phase image of same field (left).](http://images.novusbio.com/fullsize/LYVE-1-Antibody-ALY7-Immunohistochemistry-NBP1-43411-img0004.jpg "Immunohistochemistry: LYVE-1 Antibody (ALY7) [NBP1-43411] - Immunohistochemistry of cryosections of mouse intestine at 2.5 ug/ml of anti-mouse LYVE-1 antibody followed by Anti-Rat IgG Rhodamine (right). Phase image of same field (left).")
![Flow Cytometry: LYVE-1 Antibody (ALY7) [NBP1-43411] - Analysis using the Biotin conjugate of NBP1-43411. Staining of LYVE-1 transfected cells with 0.06 ug of Rat IgG1 k Isotype Control Biotin (blue histogram) or 0.06 ug of Anti-Mouse Lyve-1 Biotin (purple histogram) followed by Streptavidin PE.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-ALY7-Flow-Cytometry-NBP1-43411-img0006.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (ALY7) - BSA Free [NBP1-43411] - Ang II treatment promotes lymphatic marker expression of LECs in vitro. (A) Immunofluorescence staining of LECs with anti-LYVE-1 & anti-VEGFR-3 antibodies. (B) LECs were treated with Ang II (500 nM) for 12 & 24 h, the mRNA levels of LYVE-1, VEGFR-3 & Prox1 were detected by qPCR, & the data were normalized using the reference gene GAPDH (n = 6). (C) The protein expression level of VEGFR-3 was measured by immunoblotting & normalized using beta -actin (n = 4). The results are expressed as the means ± SD, & n represents the number of independent experiments. *P < 0.05, **P < 0.01, & ***P < 0.001 versus Control. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33013481), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-43411_rat-monoclonal-lyve-1-antibody-aly7-310202415171341.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (ALY7) - BSA Free [NBP1-43411] - Ang II infusion increases cardiac lymphangiogenesis via AT1R in vivo. (A) Wild-type mice were subcutaneously infused with Ang II (1,000 ng/kg/min) with or without losartan (10 mg/kg) for 1 or 2 weeks, & the systolic blood pressure was measured by the tail-cuff method (n = 6). (B) Cardiac mRNA expression level of LYVE-1 was measured by qPCR analysis (n = 3). (C) Cardiac mRNA expression level of VEGFR-3 was measured by qPCR analysis (n = 3). (D) Immunofluorescence staining of hearts with anti-LYVE-1 (Red) & anti- VEGFR-3 (Green) antibodies & DAPI (Blue) (Left, n = 6), & the quantification of the LYVE-1+ & Prox1+ lymphatic vessels in the hearts (Right, n = 6). The results are expressed as the means ± SD, & n represents the number of independent experiments. *P < 0.05, **P < 0.01, & ***P < 0.001 versus Sham group; #P < 0.05, ##P < 0.01, & ###P < 0.001 versus Ang II 1W + Saline group; $$$P < 0.001 versus Ang II 2W + Saline group. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33013481), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-43411_rat-monoclonal-lyve-1-antibody-aly7-310202416165617.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (ALY7) - BSA Free [NBP1-43411] - Molecular characterization of LECs in the SCS ceiling with RNA FISH.(A-B) Expression of new cLEC/cluster 2 marker genes Ackr3 (A) & Btnl9 (B) by RNA sequencing (left panels) & RNA FISH (right panels). As GFP fluorescence is lost during tissue processing for RNA FISH, immunofluorescence staining for ANXA2 (red) & LYVE1 (green) served as markers for cLECs & fLECs, respectively. Arrows point to cLECs expressing Ackr3 & Btnl9 transcripts (white). ACKR3, atypical chemokine receptor 3; ANXA2, annexin A2; Btnl9, butyrophilin like 9; cLEC, ceiling LEC; FISH, fluorescence in situ hybridization; fLEC, floor-lining LEC; LEC, lymphatic endothelial cell; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; SCS, subcapsular sinus; UMAP, Uniform Manifold Approximation & Projection. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32251437), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-43411_rat-monoclonal-lyve-1-antibody-aly7-31020241616568.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (ALY7) - BSA Free [NBP1-43411] - Molecular characterization of LECs in the SCS ceiling with immunofluorescence staining.(A–C) Expression of new cLEC/cluster 2 marker genes ANXA2 (A), FABP4 (B), & CD36 (C) by RNA sequencing (left panels) & immunofluorescence staining (right panels) in Ackr4-GFP reporter mice. GFP (white) & immunofluorescence costaining for LYVE1 (green) served as markers for cLECs & fLECs, respectively. ACKR4, atypical chemokine receptor 4; ANXA2, annexin A2; CD, cluster of differentiation; cLEC, ceiling LEC; FABP4, fatty acid binding protein 4; fLEC, floor-lining LEC; GFP, green fluorescent protein; LEC, lymphatic endothelial cell; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; SCS, subcapsular sinus; UMAP, Uniform Manifold Approximation & Projection. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32251437), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-43411_rat-monoclonal-lyve-1-antibody-aly7-310202416171489.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (ALY7) - BSA Free [NBP1-43411] - Molecular characterization of LECs in the SCS ceiling with immunofluorescence staining.(A–C) Expression of new cLEC/cluster 2 marker genes ANXA2 (A), FABP4 (B), & CD36 (C) by RNA sequencing (left panels) & immunofluorescence staining (right panels) in Ackr4-GFP reporter mice. GFP (white) & immunofluorescence costaining for LYVE1 (green) served as markers for cLECs & fLECs, respectively. ACKR4, atypical chemokine receptor 4; ANXA2, annexin A2; CD, cluster of differentiation; cLEC, ceiling LEC; FABP4, fatty acid binding protein 4; fLEC, floor-lining LEC; GFP, green fluorescent protein; LEC, lymphatic endothelial cell; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; SCS, subcapsular sinus; UMAP, Uniform Manifold Approximation & Projection. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32251437), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-43411_rat-monoclonal-lyve-1-antibody-aly7-31020241618925.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (ALY7) - BSA Free [NBP1-43411] - Molecular characterization of LECs in the SCS ceiling with immunofluorescence staining.(A–C) Expression of new cLEC/cluster 2 marker genes ANXA2 (A), FABP4 (B), & CD36 (C) by RNA sequencing (left panels) & immunofluorescence staining (right panels) in Ackr4-GFP reporter mice. GFP (white) & immunofluorescence costaining for LYVE1 (green) served as markers for cLECs & fLECs, respectively. ACKR4, atypical chemokine receptor 4; ANXA2, annexin A2; CD, cluster of differentiation; cLEC, ceiling LEC; FABP4, fatty acid binding protein 4; fLEC, floor-lining LEC; GFP, green fluorescent protein; LEC, lymphatic endothelial cell; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; SCS, subcapsular sinus; UMAP, Uniform Manifold Approximation & Projection. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32251437), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-43411_rat-monoclonal-lyve-1-antibody-aly7-310202416175280.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (ALY7) - BSA Free [NBP1-43411] - Molecular characterization of LECs in the SCS ceiling with RNA FISH.(A-B) Expression of new cLEC/cluster 2 marker genes Ackr3 (A) & Btnl9 (B) by RNA sequencing (left panels) & RNA FISH (right panels). As GFP fluorescence is lost during tissue processing for RNA FISH, immunofluorescence staining for ANXA2 (red) & LYVE1 (green) served as markers for cLECs & fLECs, respectively. Arrows point to cLECs expressing Ackr3 & Btnl9 transcripts (white). ACKR3, atypical chemokine receptor 3; ANXA2, annexin A2; Btnl9, butyrophilin like 9; cLEC, ceiling LEC; FISH, fluorescence in situ hybridization; fLEC, floor-lining LEC; LEC, lymphatic endothelial cell; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; SCS, subcapsular sinus; UMAP, Uniform Manifold Approximation & Projection. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32251437), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-43411_rat-monoclonal-lyve-1-antibody-aly7-310202416175248.jpg)
![Immunocytochemistry/Immunofluorescence: Amylin Antibody (R10/99) [NB600-713] - Staining of paraffin embedded human pancreas using Guinea Pig anti-Pig Insulin antibody (A) and Mouse anti-Human Amylin antibody (B). Merged image showing co-localization of the two proteins (C). DAPI was used as nuclear counterstain (blue)](http://images.novusbio.com/fullsize/Amylin-Antibody-R10-99-Immunocytochemistry-Immunofluorescence-NB600-713-img0003.jpg "Immunocytochemistry/Immunofluorescence: Amylin Antibody (R10/99) [NB600-713] - Staining of paraffin embedded human pancreas using Guinea Pig anti-Pig Insulin antibody (A) and Mouse anti-Human Amylin antibody (B). Merged image showing co-localization of the two proteins (C). DAPI was used as nuclear counterstain (blue)")
![Immunohistochemistry-Paraffin: Amylin Antibody (R10/99) [NB600-713] - Human pancreas with Mouse anti Human Amylin Peptide, showing labeling of Islet of Langerhans.](http://images.novusbio.com/fullsize/Amylin-Antibody-R10-99-Immunohistochemistry-Paraffin-NB600-713-img0001.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody [NBP1-86571] - Staining of human endometrium shows moderate to strong secreted positivity.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Immunohistochemistry-Paraffin-NBP1-86571-img0010.jpg "Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody [NBP1-86571] - Staining of human endometrium shows moderate to strong secreted positivity.")
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody [NBP1-86571] - Staining of human placenta shows moderate to strong cytoplasmic positivity in vascular endothelial cells.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Immunohistochemistry-Paraffin-NBP1-86571-img0008.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody [NBP1-86571] - Staining of human prostate shows moderate to strong cytoplasmic positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Immunohistochemistry-Paraffin-NBP1-86571-img0009.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody [NBP1-86571] - Staining of human skeletal muscle shows weak to moderate cytoplasmic positivity in myocytes.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Immunohistochemistry-Paraffin-NBP1-86571-img0011.jpg)
![Western Blot: Jagged 1 Antibody (J1G53-3) [NBP3-11671] -](http://images.novusbio.com/fullsize/Jagged-1-Antibody-J1G53-3-Western-Blot-NBP3-11671-img0003.jpg "Western Blot: Jagged 1 Antibody (J1G53-3) [NBP3-11671] -")
![Immunohistochemistry: Jagged 1 Antibody (J1G53-3) [NBP3-11671] - Immunohistochemical staining of JAG1 using Jagged 1 antibody (J1G53-3) in Pancreas, Acini and Duct (2.5 ug/ml). This antibody has been tested in immunohistochemistry, analyzed by an anatomic pathologist and validated for use in IHC applications against formalin-fixed, paraffin-embedded human tissues. The image shows the localization of the antibody as the precipitated red signal, with a hematoxylin purple nuclear counterstain.](http://images.novusbio.com/fullsize/Jagged-1-Antibody-J1G53-3-Immunohistochemistry-NBP3-11671-img0001.jpg)
![Flow Cytometry: Jagged 1 Antibody (J1G53-3) [NBP3-11671] - FACS staining of human Lymphocyte(CD4+) using Jagged 1 antibody (J1G53-3) (PerCP).](http://images.novusbio.com/fullsize/Jagged-1-Antibody-J1G53-3-Flow-Cytometry-NBP3-11671-img0002.jpg)
![Surface Plasmon Resonance: Jagged 1 Antibody (J1G53-3) [NBP3-11671] - SPR analysis of the interaction between Jagged 1 antibody (J1G53-3) derivative hJagged1-Fc fusion protein. SPR response was taken when 13, 6.5, 3.25, 1.625, and 0.8125nM of J1G53-3 were injected onto the hJagged1-Fc fusion protein. J1G53-3 exhibited the highest binding affinity, and its property and binding ability was studied in detail by spectroscopy and surface Plasmon resonance (SPR). The result acquired through SPR was as follows: Kd value was 1.08nM and value of chi-square was 0.0237 through SPR analysis.](http://images.novusbio.com/fullsize/Jagged-1-Antibody-J1G53-3-Surface-Plasmon-Resonance-NBP3-11671-img0004.jpg)
